[Federal Register Volume 78, Number 213 (Monday, November 4, 2013)]
[Notices]
[Page 66021]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-26310]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Cures Acceleration Network Review Board.
    The meeting will be open to the public, viewing virtually by WebEx.
    Individuals can view and access the meeting by the link below. 
https://ncatsevents.webex.com/ncatsevents/onstage/g.php?t=a&d=661895283.
    1. Go to ``Event Status'' on the left hand side of page, then click 
(Register) to complete required registration prior to joining this 
event.
    2. ``Join Event Now'' on the right hand side of the page will 
automatically populate with your First Name, Last Name, and Email 
Address. Click ``Join Now.''
    Event number: 661 895 283.
    Call-in toll-free number (US/Canada): 1-855-244-8681.
    Call-in toll number (US/Canada): 1-650-479-3207.
    Access code: 661 895 283.

    Name of Committee: Cures Acceleration Network Review Board.
    Date: December 12, 2013.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: The CAN Review Board will meet virtually to discuss how 
NCATS might optimally exercise its flexible research authority by 
using transactions other than grants, cooperative agreements and 
contracts.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Danilo A Tagle, Ph.D., Executive Secretary, 
National Center for Advancing Translational Sciences, 1 Democracy 
Plaza, Room 992, Bethesda, MD 20892, 301-594-8064, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: October 30, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-26310 Filed 11-1-13; 8:45 am]
BILLING CODE 4140-01-P